We have confirmed our previous findings that the third generation TKI osimertinib instead of inhibiting, induces STAT3 and YAP1 (PC9 and H1975) in addition to Src and CDCP1 phosphorylation (only PC9) in the PC9 and H1975 EGFR-mutation positive NSCLC cell lines 8-10. Here, EGFR is linked to non-small cell lung carcinoma.